Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment

PURPOSE: Omalizumab is a humanized anti-immunoglobulin (Ig) E monoclonal antibody that is effective in treating some patients with chronic spontaneous urticaria (CSU) who do not respond to antihistamines. Gut microbiome plays a role in the pathogenesis of allergies and autoimmune diseases. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mei, Zhao, Leran, Wang, Kun, Qin, Yongzhang, Jin, Jingji, Wang, Dong, Yan, Huimin, You, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907007/
https://www.ncbi.nlm.nih.gov/pubmed/36762258
http://dx.doi.org/10.2147/CCID.S393406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907007/
https://www.ncbi.nlm.nih.gov/pubmed/36762258
http://dx.doi.org/10.2147/CCID.S393406

Ejemplares similares